The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer.
about
Galeterone for the treatment of advanced prostate cancer: the evidence to dateTechnical challenges in the isolation and analysis of circulating tumor cellsSingle-Cell Analysis of Circulating Tumor Cells as a Window into Tumor HeterogeneityCellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival.Activation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progression.Liquid biopsy: ready to guide therapy in advanced prostate cancer?The Cohesive Metastasis Phenotype in Human Prostate Cancer.The molecular underpinnings of prostate cancer: impacts on management and pathology practice.Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer.Emerging Variants of Castration-Resistant Prostate Cancer.Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed?Prostate Cancer Stem Cell Markers Drive Progression, Therapeutic Resistance, and Bone Metastasis.Recent advances in circulating tumor cells and cell-free DNA in metastatic prostate cancer: a review.Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer.Androgen receptor expression on circulating tumor cells in metastatic breast cancer.Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation.Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer (CRPC).Synaptophysin expression on circulating tumor cells in patients with castration resistant prostate cancer undergoing treatment with abiraterone acetate or enzalutamide.CTC-derived AR-V7 detection as a prognostic and predictive biomarker in advanced prostate cancer.Contemporary molecular tests for prognosis and treatment guidance for castration-resistant prostate cancer.Understanding cancer lineage plasticity: reversing therapeutic resistance in metastatic prostate cancer.Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer.Label-free isolation of prostate circulating tumor cells using Vortex microfluidic technology.
P2860
Q26739887-22353A80-0033-4E37-BCD8-01914A1A3950Q26741646-A7ABD72A-43BB-4BC8-BCDA-090E37A991D0Q33883227-3CFE7D28-529D-49EA-A3A1-1672E9D90611Q36356608-56BD8A55-B6E9-4A15-8BCE-3511456841ADQ37641718-2490EFEC-1F39-4C2C-B451-96E6782B73A1Q38840458-A3FE09EC-5A03-4EF8-8533-172A869BDA30Q38966462-85FE883B-3646-4082-84DE-0BEB5A68BA0CQ38983790-4D9AA8BF-4B21-42E4-B499-43658C50DEE5Q39016544-FCC614FD-348D-4254-BB37-8980F40C4182Q39210257-AF0A3144-5FBC-4FD1-B155-1DCDC0B14134Q39218490-562A3687-B33F-4026-87A5-2A85DEFB60A1Q39424549-BFA09ADB-0C3E-4ACF-BA1E-8BE3ACD3BA6FQ39454057-F1D0F6CF-AA32-4050-A38E-01B232CC14E4Q40496979-51F80BA7-D0C3-492F-8B35-DDFB0603D2E2Q42366191-6F977E30-9D1F-4D5B-9976-7A9AF24735B6Q42390872-5FCE217C-1B7A-48F3-965B-C5A760664177Q47269802-1E99A630-6F79-4115-A1EB-B8247D37C478Q47561890-1FB1F1B6-4633-4147-80CF-A3A52B70A586Q47740995-408222A1-8768-4CEE-8D0C-F5D6008B79DDQ51465026-38F96E35-BC0E-4185-92B9-CCCF55F5147DQ53741551-82FB3845-4420-4A63-AC16-59A07D4AFE69Q55343494-A897782B-9C05-4EEB-B44D-FB2A5C986D0FQ55394255-64A1C5FE-6CE5-482A-9EEE-9DCB0DCD7A06
P2860
The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The Initial Detection and Part ...... euroendocrine Prostate Cancer.
@en
type
label
The Initial Detection and Part ...... euroendocrine Prostate Cancer.
@en
prefLabel
The Initial Detection and Part ...... euroendocrine Prostate Cancer.
@en
P2093
P2860
P1476
The Initial Detection and Part ...... euroendocrine Prostate Cancer.
@en
P2093
Adam Jendrisak
David M Nanus
Dena Marrinucci
Himisha Beltran
Howard I Scher
Jessica Louw
Juan Miguel Mosquera
Mark Landers
Myriam Kossai
Nicole A Schreiber
P2860
P304
P356
10.1158/1078-0432.CCR-15-0137
P407
P577
2015-12-15T00:00:00Z